Project Grant K08AI187714
Award Date
5/8/25
Completion Date
4/30/30
Dollars Obligated
$200K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $343,744 to develop a comprehensive product development strategy for an Investigational New Drug (IND) submission. The goal is to facilitate Phase I clinical trials of a novel gene therapy approach using chimeric antigen receptor (CAR)-modified hematopoietic stem/progenitor cells to functionally cure HIV infection. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,797,623 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at understanding the significance of pathogen genetic variation and evolution. The grant, with a period of performance from July 2024 to May 2029, will utilize a combination of genetics and experimental evolution to investigate complex epistasis...
The University of California, San Diego (UCSD) was awarded a $192,788 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, with a period of performance from November 2024 to October 2026, aims to conduct a genome-wide screening study to identify regulators of plasmacytoid dendritic cell (pDC) function and exhaustion. This research is intended to provide novel insights into the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $417,984 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute in La Jolla, California. The grant, with a performance period from March 7, 2025 to February 28, 2026, supports research aimed at identifying actionable targets for the selective induction of regulatory T cell (Treg) differentiation to facilitate the development of stem cell-based therapies...
This Project Grant award of $453,900.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research program supports research to develop a genome editing platform based on phage recombinases that can operate across a broad range of bacterial species, including clinically relevant pathogens. The award to the University of Rochester aims to transform genetic manipulation capabilities for bacteria by leveraging phage proteins...
This federal Project Grant award, with an ID of DP2AI184830, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $492,000 grant is funding research at the University of California, San Francisco (UCSF) to systematically investigate the mechanisms governing immunogenic cell death (ICD) - a critical process for launching effective immune responses against viral pathogens and tumors. The...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,072,951 in funding to the National Marrow Donor Program (NMDP) to conduct clinical and mechanistic studies examining optimal preparative approaches for infants with severe combined immunodeficiency (SCID). The goal of the project is to compare the efficacy and safety of low-dose versus moderate-dose busulfan...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $561,030 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Children's Research Institute to develop a novel cell therapy for preventing and treating viral infections in immunocompromised patients following hematopoietic stem cell transplantation. The project aims to enhance the efficacy of virus-specific T cell therapies by genetically modifying the cells to be resistant to alemtuzumab, an...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $417,729 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of California, Davis to establish in vitro cell models for studying the reactivation of inherited chromosomally integrated human herpesvirus 6 (ICIHHV-6). The goal is to develop induced pluripotent stem cell (iPSC) and neural stem cell models to examine the triggers and mechanisms of ICIHHV-6 reactivation, which has been...
This $474,620 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research at the University of California, San Francisco (UCSF) to comprehensively define the selective pressures on the HIV-1 capsid. The project aims to use a high-throughput saturating mutagenesis approach to identify capsid mutations that allow the virus to evade human restriction factors, as well as those...